Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07420556
Eligibility Criteria:
Inclusion Criteria:
Participants must meet all of the following criteria to be included in the study:
Aged 18-24 years,
Residing in Afşin district, Kahramanmaraş province,
Willing to voluntarily participate in the study,
Literate and able to understand survey questions in Turkish,
Have not previously received the HPV vaccine,
Agree to be available throughout the study period (pre-test, post-education test, and 1-month follow-up test),
Young women without physical or cognitive impairments or serious health problems that would prevent participation in the study.
Exclusion Criteria:
Participants will be excluded if they meet any of the following conditions:
Under 18 or over 24 years of age,
Have received the HPV vaccine or started the vaccine series,
Have been diagnosed with HPV infection,
Unable to attend the educational sessions or complete all stages of data collection (pre-test, post-education test, 1-month follow-up test),
Illiterate or unable to understand the study forms in Turkish,
Withdraw from the study or indicate unwillingness to continue participation,
Have serious hearing, vision, or cognitive impairments that would prevent meaningful engagement in the educational sessions.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
24 Years
Study:
NCT07420556
Study Brief:
Protocol Section:
NCT07420556